In conclusion, this study suggests that in community settings, a few simple cognitive questions can reveal the risk of several medical conditions and that the addition of biological information, especially GFAP and APOE ε4, could add specificity and has the potential to be used as a screening instrument in primary care for differentiating between risk assessment of future dementia and depression. This evidence concerns the gene APOE and major depressive disorder.